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Bullfrog thyroglobulin was digested with lysyl endopeptidase, known to be highly specific to cut the C-terminal side of lysine residue in protein. 
after reduction and carboxymethylation. We isolated one peptide which lacked the C-terminal lysine, and which corresponds to 103-129 of bovine 
thyroglobulin sequence. Tyrosine 130 in the mammalian thyroglobulin molecule is known to be an iodination site. These findings suggest that 
tyrosine 130 in frog thyroglobulin is a thyroid hormone generating site. 
Bullfrog thyroglobulin: Partial amino acid sequence; Thyroid hormone generating site 
I. INTRODUCTION 
Thyroid hormone is synthesized by iodination of a 
particular tyrosine residue and the transfer of an iodo- 
phenoxyl group from a 'donor' to an 'acceptor' iodoty- 
rosine residue within the thyroglobulin (TG) molecule. 
This coupling reaction results in the conversion of an 
acceptor to a thyroid hormone residue, and a donor to 
a dehydroaIanine residue [1,2]. Thus, the peptide bonds 
of both sides of the acceptor site should be cleaved in 
the process of thyroid hormone release, whereas those 
of the donor site remain intact [2]. Five tyrosine residues 
have been suggested as the acceptor site at 5, 1291,2555, 
2569 and 2748 in a few mammalian TG [3-7]. We have 
recently demonstrated the 4 donor tyrosine residues at 
5,926, 986 or 1008 and 1375 by the analysis ofdehydro- 
alanine containing peptide in bovine TG [8]. Tyrosine 
residues at 5 and 239 [9], and 130 [10], 2469 and/or 2559 
[11] have also been suggested to be the donor site. In the 
present study, we show evidence supporting that tyro- 
sine 130 is the 'acceptor site' in bullfrog TG. 
2. MATERIALS AND METHODS 
2.1. Chemical modification and en:ymatic digestion of frog TG 
TG from the thyroid glands of bullfrog tadpole (stage XVII-XX 
[12]), Rana catesbeiana, was prepared as in [13]. Frog TG was reduced 
and carboxy-methylated (RCM) according to Crestifield et al. [14]. 
then dialysed against 4 M guanidine-HCl/50 mM Tris, pH 9.0 to 
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remove xcess reagents. RCM-frog TG ( 15 rag) was digested with 0,15 
mg of lysyl endopeptidase (Wako Pure Chemicals, [EC 3.4.21.4]) at 
37°C in 4 r,,4 guanidine-HCI/50 mM Tris, pH 9.0. After 3 h, 0.15 mg 
of the enzyme was further added and kept another 3 h, then the pH 
dropped to ca. 2 with 10% aqueous trifluoroacetic acid to stop the 
digestion. 
2.2. Sepctration of peptides 
The digest obtained above was diluted with 5 vols of water. After 
centrifugation at 15 000 rpm for 30 rain to remove insoluble materials 
formed by dilution, the supernatant fraction was desalted through 
Nucleosil 5C18 column (8×250mm). Peptides were recovered by elu- 
tion with 60% acetonitrile/0.1% trifluoroacetic acid. Peptides were 
fractionated by ion-exchange and reverse-phase HPLC. 
2.2. Am#to acM analysis and sequence determOtation 
Peptides were hydrolyzed in the gas phase with constant boiling HCI 
containing 0.2% phenol at I I0°C for 24 h under reduced pressure. 
Amino acid analysis was performed on a Hitachi 835 amino acid 
analyzer. Amino acid sequences of peptides were determined by a 
gas-phase automatic sequence analyzer (Applied Biosystems 477A 
with on-line 120A phenyl thiohydantoin amino acid analyzer). 
3. RESULTS AND DISCUSSION 
3.1. Characteri-ation of fi'og TG 
Bullfrog TG had a molecular size similar to that of 
bovine TG on the 8-25% SDS-polyacrylamide g l elec- 
trophoresis without the reducing reagent on the Phast 
System (Pharmacia), The amino acid composition is 
roughly similar between frog and bovine TG [13]. 
3.2. Isolation of lysyl endopeptidase digested peptid,, 
The peptide fraction from Nucleosil 5C18 column 
was dried and dissolved in 10 ml of 50 mM Tris-HCl 
buffer, pH 9.0, and applied to a Mono Q column (Phar- 
macia, 5×50 mm), which was previously equilibrated 
with 50 mM Tris.HCl, pH 9.0. Peptides were eluted with 
a 60 rain linear gradient (0-0.5 M) of NaC1 in the same 
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buffer at a flow rate of 1 ml/min and room temperature, 
and collected in 14 fractions (A-N by elution order). 
Peptides in three of those fractions (C, L and M) were 
further separated on a reverse-phase HPLC using a 
Chemco3Cl8 (6× 100 mm) column with a 60 min linear 
gradient (5-60%) of acetonitrile in 0.1% aqueous tri- 
fluoroacetic acid at 40°C, and the flow rate of I ml/min. 
Fig. 1 shows a representative chromatographic elution 
profile. 
3.3. Amhto acM sequence detetvnh~ation and comparison 
with botrhte TG sequence 
The amino acid sequences of 5 peptides with high 
recovery (30-35%) among 20 purified peptides were de- 
termined. Considering the maximum homology, 4 pep- 
tides L44 (and M44), C19, L51 (and M51) and C45 
could be located at the amino terminal, central and 
carboxy terminal portion in bovine TG sequence pre- 
dicted from the eDNA nucleotide sequence [6], respec- 
tively, as shown in Fig. 2. In peptide C19, two X should 
be Thr or Tyr, judging from the amino acid composi- 
tion. Possible reasons for the failure to identify these 
two residues are phosphorylation or O-linked sugar 
chain for Thr and iodination for Tyr. Peptide L44 (and 
M44), L51 (and M51) and C45 are homologous with the 
bovine TG sequence 103-129, 1428-1467 and 2039- 
2065, in 60, 40 and 50%, respectively. Peptide C19 sho- 
uld correspond to the bovine TG sequence 299-311, 
with a maximum of 38% homology. One peptide (Tyr- 
Phe-Cys-Val-Asp-Asn-Ser-Gly-Lys) could not be lo- 
cated in the bovine TG sequence with homology. All the 
peptides equenced above except peptide L44 (M44), 
have lysine at the C-terminus, according to the specifi- 
city or the lysyl endopeptidase. This enzyme is known 
to be highly specific to cut the C-terminal side of the 
lysine residue. Our previous observations of the specifi- 
city of this enzyme applied to other proteins also show 
that the cutting site is strictly limited to the lysine resi- 
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Fig. 1. Purification of Mono Q chromatography fraction on reverse- 
phase HPLC. Fraction L on Mono Q chromatography was adjusted 
to pH 2 with trifluoroacetic acid, and applied to a Chemco 3C18 
column (6x 100 mm), previously equilibrated with 5% acelonitrile in 
0. 1% aqueous trifluoroacetic acid. Peptides were eluted with a 60 rain 
linear gradient from 5 to 60% of acetonitrile in 0.1% aqueous trifluo- 
roacetic acid at a flow rate of 1 ml/min and 40°C. One-ml fractions 
were collected. ( ), A.,30; ( . . . .  ), acetonitrile concentration. 
terminal side of peptide L44 is already cleaved before 
lysyl endopeptidase digestion. This means that this is 
one of the naturally cleaved sites as suggested by Marriq 
et al. [10]. 
In the bovine TG sequence, residue 130 is known to 
be Tyr, and one of the iodination sites. Marriq et al. [I0] 
suggested that Tyr 13° is the natural cleavage point in a 
fully iodinated bovine TG molecule, and to be one of 
the donor sites by assuming that the resultant dehydro- 
alanine is unstable. However, our previous studies on 
bovine TG showed the dehydroalanine, resulting from 
the loss ofiodophenoxy group at the donor site is stable 
[8]. Thus, natural cleavage sites should include the 'ac- 
ceptor' sites. As stated in section 1, both side peptide 
bonds at the acceptor tyrosine should be cleaved when 
Bov ine :  
Bul l frog' ,  
1 103  130 
N . . . . .  DSGDYS PVQCD L R R R Q C W C V D A E G M E V Y  - - - 
N ,  , E . E D  . . . .  RQLGE . . . . .  N . . . .  I 
(L44, M44)  
29~ 311 
- . S C H P D G E Y Q A A Q C  - - 
,VX ,  $AVX,  ,S  LK  
(C19) 
I 42  B 1 467 
• " " R V V A A S D A S Q D A  L G C V K C P E G S Y  FQDEQC I P C P A G F Y Q E Q  - 
LL  I S R A , E  I G N V A . . G  I • ,V  • .ESE  ,GE  *V ,  , .H  . . . .  YK  
(L51 ,M51 )
2039 2O65 2750 
- - • TYPFGWYQKP<: .VS  P S D A P S F C P S V A  LPA . . . .  K 
• S . . . . . . . .  G , E G ,  I L oGL .  , T A D V L K  
(c45) 
Fig. 2. Alignment of bullfrog thyroglobulin fragment with deduced bovine TG sequence [6]. Number over sequence indicate the amino acid residue 
number or bovine TG. The peptide name is shown in parentheses, The substituted amino acid residue from bovine TG is shown by one letter. (X), 
unidcntitlcd (Thr or Tyr): (.). residue identical to that of bovine TG: (<>), deletion. 
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the thyro id  hormone is generated.  On  the assumpt ion  
that  the TG sequence around those regions is conserved 
dur ing  the evo lut ion,  we suggest hat  Tyr  z3° in bul l f rog 
TG is the accepter  site. 
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